Pyoderma gangrenosum secondary to total hip replacement
Ital J Dermatol Venerol
.
2021 Dec;156(Suppl. 1 to No. 6):27-28.
doi: 10.23736/S2784-8671.19.06256-4.
Epub 2019 Apr 23.
Authors
Filomena Russo
1
,
Virginia Mancini
2
,
Maria L Flori
3
,
Piergiorgio Pelosi
4
,
Serafino Carta
4
,
Luca Provvidenziale
3
,
Michele Pellegrino
5
,
Paolo Taddeucci
3
,
Michele Fimiani
3
Affiliations
1
Section of Dermatology, Department of Clinical Medicine and Immunological Science, University of Siena, Siena, Italy - file.russo@libero.it.
2
Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena, Italy.
3
Section of Dermatology, Department of Clinical Medicine and Immunological Science, University of Siena, Siena, Italy.
4
Department of Orthopedics and Traumatology, University of Siena, Siena, Italy.
5
Section of Dermatology, Department of Dermatology, Misericordia Hospital, Grosseto, Italy.
PMID:
31042853
DOI:
10.23736/S2784-8671.19.06256-4
No abstract available
MeSH terms
Arthroplasty, Replacement, Hip* / adverse effects
Diagnosis, Differential
Humans
Pyoderma Gangrenosum* / diagnosis